News|Articles|February 11, 2025
Unlocking the Power of Research-Ready Data for Life Sciences
Author(s)LexisNexis® Risk Solutions
Related Content
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
The New Healthy Aging Imperative and What It Means for Pharma
4
The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distribution Channels
5